Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

BACKGROUND: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. METHODS: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Adrianna, Palafox, Benjamin, O'Donnell, Owen, Stuckler, David, Perel, Pablo, AlHabib, Khalid F, Avezum, Alvaro, Bai, Xiulin, Chifamba, Jephat, Chow, Clara K, Corsi, Daniel J, Dagenais, Gilles R, Dans, Antonio L, Diaz, Rafael, Erbakan, Ayse N, Ismail, Noorhassim, Iqbal, Romaina, Kelishadi, Roya, Khatib, Rasha, Lanas, Fernando, Lear, Scott A, Li, Wei, Liu, Jia, Lopez-Jaramillo, Patricio, Mohan, Viswanathan, Monsef, Nahed, Mony, Prem K, Puoane, Thandi, Rangarajan, Sumathy, Rosengren, Annika, Schutte, Aletta E, Sintaha, Mariz, Teo, Koon K, Wielgosz, Andreas, Yeates, Karen, Yin, Lu, Yusoff, Khalid, Zatońska, Katarzyna, Yusuf, Salim, McKee, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905400/
https://www.ncbi.nlm.nih.gov/pubmed/29433667
http://dx.doi.org/10.1016/S2214-109X(18)30031-7

Ejemplares similares

Ejemplares similares